Aims/Purpose: Dexpanthenol (Dxp) is a common excipient in topical formulations used in dermatology and ophthalmology. However, little is known about the absorption of Dxp into biological tissues. In this study we investigated the transfer of Dxp into the anterior segment – i.e. cornea and aqueous humor – first, from contact lenses (CL) following treatment with SOLOCARE AQUA® care solution and second, after administration of Bepanthen® and Siccaprotect® eye drops. All products contained approximately equivalent amounts of Dxp (2–3%).Methods: A bioanalytical method for the quantification of Dxp by UHPLC MS/MS was validated. The initial experiments evaluated the ad/absorption of Dxp from the SOLOCARE AQUA® care solution onto FDA class representative CL. Then, ex vivo porcine eye globes were mounted in an eye globe holder developed inhouse, with simulated tear flow, and Dxp uptake into the anterior segment from SOLOCARE AQUA® treated CL and eye drops was investigated.Results: Dxp ad/absorption in CL was correlated to exposure time and CL material. Following exposure to Dxp‐soaked CL and eye drops, transport of Dxp through porcine cornea to the aqueous humor was found in all experimental conditions. However, there was a statistically significant difference in the concentrations measured after CL application and eye drop instillation. Direct application of Dxp containing eye drops resulted in higher Dxp deposition in the anterior segment than the SOLOCARE AQUA® treated CL.Conclusions: In this benchmark study we investigated the deposition of Dxp in the anterior segment of excised porcine eyes from CL treated with a care solution and commercially available eye drops. Despite the excipient Dxp being classified as Generally Recognized as Safe (GRAS), the inferior absorption of the substance from SOLOCARE AQUA® washed CL compared to approved Dxp containing eye drops is considered preferable with regard to medical device safety.
Read full abstract